Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 170.00
+2.00 (1.19%)
Apr 20, 2026, 1:13 PM CST
Alar Pharmaceuticals Revenue
In the year 2025, Alar Pharmaceuticals had annual revenue of 2.75M TWD, down -52.67%. Alar Pharmaceuticals had revenue of 1.50M in the quarter ending December 31, 2025.
Revenue
2.75M
Revenue Growth
-52.67%
P/S Ratio
4,076.43
Revenue / Employee
n/a
Employees
27
Market Cap
11.22B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.75M | -3.06M | -52.67% |
| Dec 31, 2024 | 5.82M | -463.46M | -98.76% |
| Dec 31, 2023 | 469.27M | 468.47M | 58,559.00% |
| Dec 31, 2022 | 800.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grape King Bio | 10.25B |
| YungShin Global Holding | 8.38B |
| Standard Chemical & Pharmaceutical | 7.02B |
| TTY Biopharm Company | 6.45B |
| Synmosa Biopharma | 6.19B |
| Formosa Laboratories | 4.85B |
| ScinoPharm Taiwan | 3.16B |
| Handa Pharmaceuticals | 1.73B |